DHG Pharmaceutical Fined, Ordered to Pay Over VND 10 Billion in Back Taxes
This Aveluro analysis covers DHG in the Dược phẩm sector. The classified event type is regulation change, with negative sentiment and a deterministic market-impact score of 7.0/10. Aveluro classifies this story as a negative catalyst and risk signal for the affected stock. Source coverage came from CafeF - Doanh nghiệp, classified as a primary/top-tier source.
Key Facts
Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.
Follow this event and trade Vietnam stocks
Use the broker guide to compare Vietnam market access before acting on this news.
Aveluro may earn a commission from broker partners. Market data and broker availability can change; confirm access before opening an account.
Overview
DHG Pharmaceutical (DHG) has been fined and ordered to pay over VND 10 billion in back taxes and penalties by the Large Enterprise Tax Office for tax declaration errors. The company must settle the amount within 10 days or face enforcement. The penalty is modest relative to DHG’s quarterly earnings, but the event underscores regulatory scrutiny in the pharmaceutical sector.
Key Facts
- Total amount payable: VND 10 billion (approximately USD 0.4 million).
- Fine for administrative violations: VND 1.61 billion, including VND 6.5 million for procedural violations and VND 1.6 billion (20% of under-declared tax) for incorrect tax bases.
- Back taxes: VND 8 billion, comprising VND 890 million in personal income tax, VND 3.8 billion in corporate income tax, and VND 3.2 billion in value-added tax.
- Late payment interest: VND 790 million as of June 25, with additional daily interest of 0.05% on unpaid amounts.
- Payment deadline: 10 days from receipt of the decision; non-compliance may lead to enforcement.
- DHG reported Q1 2026 net revenue of VND 1,200 billion and net profit of VND 310 billion, up 18% year-on-year.
- DHG stock closed at VND 93,000 on July 14, 2026, down 0.4%.
What Happened
The Large Enterprise Tax Office issued a decision penalizing DHG for two tax declaration violations: incorrect tax bases that did not result in underpayment, and incorrect tax bases that led to underpayment. The company was fined VND 1.61 billion and ordered to pay VND 8 billion in back taxes plus VND 790 million in late payment interest, totaling over VND 10 billion.
Acting General Director Toshifumi Kojima is responsible for compliance. The company has 10 days to pay or face enforcement and additional daily penalties. DHG retains the right to appeal or initiate administrative proceedings.
Market Context
DHG shares on HOSE closed at VND 93,000 on July 14, down 0.4%, reflecting a muted immediate reaction. The fine is small relative to DHG’s Q1 2026 net profit of VND 310 billion and annual profit target of VND 1,007 billion. The pharmaceutical sector in Vietnam faces ongoing regulatory oversight on tax and pricing matters.
Strategic Significance
The tax penalty, while not material to DHG’s financials, highlights compliance risks that could affect investor sentiment. DHG’s strong Q1 performance and cost controls suggest operational resilience, but repeated regulatory issues could lead to higher scrutiny or reputational damage. The company’s ability to resolve this quickly and avoid recurrence is key to maintaining investor confidence.
What to Watch
- DHG’s payment of the VND 10 billion within the 10-day deadline.
- Any appeal or legal challenge by DHG against the tax decision.
- Q2 2026 earnings report for any impact on margins or provisions.
- Future tax compliance disclosures and any additional regulatory actions.
- Stock price reaction and foreign investor flows following the news.